Biotech company with U.S. headquarters in Montco raises $130 million in series B
March 02, 2020 at 10:48 AM EST
The company will use part of the funds to advance its proprietary pipeline of ImmTAX molecules into the clinic.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|